Newt's WorldNewt's World

Episode 509: New Alzheimer's Disease Treatment – LEQEMBI

View descriptionShare

Eisai Co., Ltd. and Biogen Inc. announced on January 6th that under the Accelerated Approval Pathway the U.S. Food and Drug Administration (FDA) has approved lecanemab-irmb, which has the brand name in the United States of LEQEMBITM, for the treatment of Alzheimer’s disease.  The approval is based on Phase 2 data that demonstrated that LEQEMBI reduced the accumulation of Aβ plaque in the brain, a defining feature of Alzheimer’s disease.  Newt’s guest is Dr. Marwan Sabbagh, MD.  He is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program and a professor in the Department of Neurology at Barrow Neurological Institute and was one of the leading doctors of the study.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Newt's World

    931 clip(s)

Newt's World

Join former House Speaker, professor, historian, and futurist Newt Gingrich as he shares his lifetim 
Social links
Follow podcast
Recent clips
Browse 922 clip(s)